WEE1 and neoplasm: Evaluation of representatives 2e and 2n of the new protein kinase inhibitor class in the cancer cell line panel of the National Cancer Institute (NCI) revealed considerable antiproliferative activity on tumor cell lines in the single digit micromolar concentration range.